News

  • 29.11.2019

    L- MAI - SAY NO TO ALLERGY!

    Allergy is one of the most widespread pathologies in the world. Allergic rhinitis and urticaria are among the most common allergic diseases. Thus, 20-40% of the world's population suffers from allergic rhinitis.At least once in a lifetime every fifth person had suffered from urticarial.

  • 26.11.2019

    ANALGETICS + SOPORIFIC = ASTENIA

    In almost every country in the world, there is a trend towards ageing of the population so the senile asthenia is growing more urgent. The researchers from the United States has detected that the use of analgesics and soporific provokes this condition. The scientists from the Florida Atlantic University have found that taking of both sleeping pills and pain medication in older age may lead to the development of senile asthenia syndrome (SAS). The risk for SAS development increases if patients took both classes of drugs concurrently.

  • 25.11.2019

    PENDING CHOLESTEROL-LOWERING DRUGS MARKET TRANSFORMATION

    Inclisiran by the Medicines Company, USA demonstrated an excellent safety profile and caused the competitors represented by Regeneron and Amgen some anxiety. The Medicines Company announced new results from a Phase 3 clinical trial of Inclisiran to reduce the low-density lipoprotein cholesterol (LDL “bad” cholesterol).The drug was evaluated in the patient population (1 561 participants) with atherosclerotic vascular disease and elevated LDL-C. The MedCo proved that the safety profile of Iinclisiran was similar with placebo.

  • 11.11.2019

    VACCINE MARKET GROWTH

    The global seasonal influenza vaccine market could reach $ 6.5 bn. by 2028. At the end of 2018, the seasonal influenza vaccine across the eight major markets was estimated at $ 4.6 billion. According to GlobalData, the analytical company, moderate growth is expected over the next 10 years on average by 3.7% annually, and by the end of 2028, this market could increase to $ 6.5 billion.

  • 06.11.2019

    CHINA AGAINST ALZHEIMER’S

    A new drug to treat Alzheimer’s disease developed by China scientists has been approved by China National Medical Products Administration. GV-971(Oligomannate), a seaweed-based drug, has been jointly developed by the Ocean University of China, the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences and Green Valley Pharmaceutical Company Ltd.

  • 08.10.2019

    PHARM BREXIT

    Manufacturers and suppliers of vital medicines and medical products say that the British authorities have not explained yet how their orders will be processed if the UK leaves the European Union at the end of October.

  • 07.10.2019

    INFLUENCE OF THE PHARMACIST ON THE CHOICE

    A study run by the marketers showed that the influence of the pharmacist on a buyer’s choice of medicine greatly depends on what kind of medicine the buyer came to the pharmacy to buy.
    Does the buyer have a doctor’s prescription, is the product intended for use in intimate places, how familiar the buyer is with the pharmacist and to what extent the buyer can trust one or another pharmacist, etc.

  • 03.10.2019

    NO TIME FOR MED REPs

    According to the survey conducted by the consulting firm Decision, the physicians in the USA are willing to devote less time communicating with medical representatives.
    Based on the survey, more than half from 1285 of the responded physicians, simply don’t have time to meet up with medical representatives.

  • 01.10.2019

    REMEDY FOR POLYCYSTOSIS TREATMENT

    Polycystic kidney disease (PKD) is a genetic condition affecting about 12 million people worldwide.
    Polycystic kidney disease is currently incurable; end-stage kidney failure requires treatment with dialysis or a kidney transplantation to prolong the life of PKD patients. But such methods are not available to everyone.

  • 24.09.2019

    NEUROCOBAL® FOR PAIN TREATMENT

    Back pain is a widespread problem - about 80% of the population of the globe regardless of the gender, race, confession, and GDP of the country they live in, least once in a lifetime suffered from back pain.
    As reported by experts of the World Health Organization, the disease prevalence reaches pandemic proportions and is an extremely serious medical and socioeconomic problem since the population of mainly working-age suffers from back pain.

  • 06.09.2019

    CHEMOTHERAPY IN TABLETS

    The U.K got a head start on clinical trials of orally administered Athenex's Oraxol in tablet and capsule that would potentially replace intravenous injections to treat cancer during chemotherapy.

  • 04.09.2019

    ALLERGY TO CATS

    The representatives of HypoCat, Swiss-based Company, inform that they have developed special vaccine for animals that makes cats hypoallergenic.
    The vaccine is specifically designed for the cats and attempts to train the immune system of cats to attack a specific protein, or allergen called Fel d 1, that the cats naturally produce. It is exactly this protein that causes the allergy in human.

  • 03.09.2019

    MONITORING ELECTRODES RED DOT™

    ECG electrodes are an important element in the information chain. They transmit the received data about the patient’s state to the monitor screen or other media. Previously, reusable electrodes applied in medicine had to be disinfected after each use. In modern medical practice, disposable electrodes are increasingly used that allows to reduce the expenditure for disinfectant gels and other similar agents.

  • 02.09.2019

    U.S. SALES SLUMPED

    Online sales crowd out drug sales via traditional pharmacy chains in the USA.
    Sales on the U.S. pharmaceutical retail market are stagnating. In early August, Walgreens, the largest U.S. drugstore chain, announced plans to close 200 stores. And drugstore chain CVS will slow the pace of its annual store expansion by reducing the plan for opening new stores by 6 times.

  • 30.07.2019

    Working is more useful than sitting in front of the TV

    Sitting in front of the TV and sitting at work impacts the cardiac function in different ways.Sitting for long periods of time has been linked to increased risk of cardiovascular disease and early death. A study led by researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that not all types of sitting are equally unhealthy.

  • 22.07.2019

    2018 MARKET LEADERS

    The updated rating of the companies ranked by sales level of RX drugs in 2018 has not brought any dramatic changes as compared with the previous year. The TOP 5 companies have not changed; some just swapped their places.

  • 19.07.2019

    FEMALE LIBIDO PILLS

    FDA (Food and Drug Administration) approved Vyleesi (bremelanotide) indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

  • 15.07.2019

    PRICE REGULATION

    The Cabinet of Ministers of Ukraine will improve regulation of prices at all medicines from the National List of Essential Medicines when making procurement for healthcare institutions financed from the budget starting from July 2019.

BaDM - We work for you!

Regional offices